CON

Over the past six months, Concentra Group Holdings Parent, Inc. (CON) stock has experienced significant positive movement, with a 72.5% increase over this period and a 75.4% increase over the past year, hitting a new 52-week high of $36.83 in early October 2026. Key events impacting the stock price include strong Q2 2026 results and raised guidance, which led to an 11.53% stock price increase on August 6, 2026, with revenue up 10.0% year-over-year to $606.0 million and net income up 45.7% to $67.3 million. S&P Global Ratings upgraded Concentra's issuer credit rating to 'BB' from 'BB-' on August 27, 2026, citing strong operating performance and lower leverage. A leadership transition is effective November 1, 2026, with Matt DiCanio becoming President and CEO, Keith Newton transitioning to Executive Chairman, and Tanner Newton appointed CFO. The company continued its expansion strategy by acquiring four medical centers in Minnesota in August 2026 and opening a new medical center in Daytona Beach, Florida, in September 2026. Additionally, a cash dividend of $0.0625 per share was declared on August 5, 2026.